Our study showed that ALKBH5 protein decreased in 3d group but increased in 7d group, suggesting that it could be one of the potential targets for treatment of stroke, and increases in demethylase may improve cerebral infarction by changing the m6A modification. Here, ALKBH5 is linked to stroke disorder.